2009-2013年天津市参保慢性阻塞性肺疾病患者住院费用结构分析

发布时间：2018-02-26 18:42

本文关键词： 慢性阻塞性肺疾病灰色关联结构变动度住院费用　出处：《中国卫生统计》2017年03期 　论文类型：期刊论文

【摘要】：目的研究2009-2013年天津市参保慢性阻塞性肺疾病(chronic obstructive pulmonary disease,COPD)患者住院费用内部影响因素及发展趋势,为合理控制医疗费用、完善医疗改革提供参考。方法采用新灰色关联法分析住院各项费用关联程度;运用结构变动值、结构变动度和结构变动贡献率等评价指标,分析5年间住院各项费用变化情况及其对总费用变化的影响程度。结果 5年间患者住院费用中,药品费关联度最大(1.0000),其次是检查费(0.7232)、治疗费(0.6841)和医用材料费(0.6438);药品费结构变动贡献率最大(36.78%),占住院总费用比例下降,其次是检查费(32.48%)和医用材料费(8.61%),占住院总费用比例上升,三者累计贡献率达77.87%。结论控制药品费应作为减少COPD患者住院费用负担的关键突破口,加强高值医用材料监管,重视医护人员劳动价值,进而优化住院费用结构。
[Abstract]:Objective to study the internal influencing factors and development trend of hospitalization expenses of patients with chronic obstructive pulmonary disease (pulmonary) in Tianjin from 2009 to 2013, in order to control the medical expenses reasonably. Methods the new grey correlation method was used to analyze the correlation degree of inpatient expenses, the structural change value, the structural change degree and the contribution rate of structural change were used. The changes of hospitalization expenses and their influence on total costs were analyzed. The most related degree of drug fee was 1.0000m, followed by examination fee (0.7232n), treatment fee (0.6841) and medical material fee (0.6438), the biggest contribution rate of structure change of drug fee was 36.78m, the proportion of total hospitalization cost decreased, the next was examination fee (32.488m) and medical material cost 8.611m, which accounted for the proportion of total hospitalization expenses. Conclusion the control of drug fees should be a key breakthrough to reduce the burden of hospitalization expenses of COPD patients, strengthen the supervision of high value medical materials, attach importance to the labor value of medical personnel, and then optimize the structure of hospitalization expenses.
【作者单位】：天津医科大学公共卫生学院卫生统计学教研室;
【基金】：国家自然科学基金(71373175) 教育部人文社会科学研究项目(11YJCZH080)
【分类号】：R563.9

【相似文献】